Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

Clinical trial NCT05627518 · COMPLETED

Trial details

NCT number: NCT05627518
Sponsor: Cinclus Pharma Holding AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Bioavailability Pharmacokinetics

Start date: 2022-11-15
Primary completion: 2022-12-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.